SynBiotic SE (DUSE: SBX)
Germany
· Delayed Price · Currency is EUR 5.36
-0.60 (-10.07%)
At close: Dec 11, 2024
SynBiotic SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Operating Revenue | 3.86 | 3.86 | 8.17 | 8.65 | 5.45 | - | Upgrade
|
| Other Revenue | - | - | - | 0.42 | 0.03 | - | Upgrade
|
| Revenue | 3.86 | 3.86 | 8.17 | 9.06 | 5.47 | - | Upgrade
|
| Revenue Growth (YoY) | - | -52.71% | -9.91% | 65.63% | - | - | Upgrade
|
| Cost of Revenue | 2.35 | 2.35 | 4.59 | 3.86 | 1.73 | - | Upgrade
|
| Gross Profit | 1.51 | 1.51 | 3.57 | 5.2 | 3.74 | - | Upgrade
|
| Selling, General & Admin | 2.51 | 2.51 | 6.02 | 2.42 | 0.73 | - | Upgrade
|
| Other Operating Expenses | 6.27 | 6.27 | 4.92 | 7.56 | 3.61 | 0.01 | Upgrade
|
| Operating Expenses | 9.92 | 9.92 | 12.9 | 10.78 | 4.57 | 0.01 | Upgrade
|
| Operating Income | -8.41 | -8.41 | -9.32 | -5.58 | -0.83 | -0.01 | Upgrade
|
| Interest Expense | -0.2 | -0.2 | -0.19 | -0.05 | -0.02 | - | Upgrade
|
| Interest & Investment Income | 0.08 | 0.08 | 0.15 | 0.13 | 0.02 | - | Upgrade
|
| Earnings From Equity Investments | -0.01 | -0.01 | -0.23 | -1.95 | -0.02 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | 0.02 | 0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.1 | 0.1 | 0.31 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -8.42 | -8.42 | -9.27 | -7.44 | -0.86 | -0.01 | Upgrade
|
| Impairment of Goodwill | -3.46 | -3.46 | -16.91 | -5.92 | - | - | Upgrade
|
| Pretax Income | -11.87 | -11.87 | -26.19 | -13.36 | -0.86 | -0.01 | Upgrade
|
| Income Tax Expense | -0.13 | -0.13 | -0.19 | -0.29 | 0.02 | - | Upgrade
|
| Earnings From Continuing Operations | -11.74 | -11.74 | -26 | -13.07 | -0.88 | -0.01 | Upgrade
|
| Minority Interest in Earnings | 1.11 | 1.11 | 1.64 | 0.35 | - | - | Upgrade
|
| Net Income | -10.63 | -10.63 | -24.36 | -12.72 | -0.88 | -0.01 | Upgrade
|
| Net Income to Common | -10.63 | -10.63 | -24.36 | -12.72 | -0.88 | -0.01 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 4 | 3 | 2 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 4 | 3 | 2 | 0 | Upgrade
|
| Shares Change (YoY) | 1799.73% | 16.35% | 33.09% | 96.39% | 524.66% | - | Upgrade
|
| EPS (Basic) | -2.24 | -2.24 | -5.97 | -4.15 | -0.56 | -0.05 | Upgrade
|
| EPS (Diluted) | -2.24 | -2.24 | -5.97 | -4.15 | -0.56 | -0.05 | Upgrade
|
| Free Cash Flow | -2.94 | -2.94 | -7.27 | -5.51 | -1.28 | -0.01 | Upgrade
|
| Free Cash Flow Per Share | -0.62 | -0.62 | -1.78 | -1.80 | -0.82 | -0.05 | Upgrade
|
| Gross Margin | 39.01% | 39.01% | 43.75% | 57.38% | 68.33% | - | Upgrade
|
| Operating Margin | -217.87% | -217.87% | -114.19% | -61.55% | -15.24% | - | Upgrade
|
| Profit Margin | -275.31% | -275.31% | -298.35% | -140.39% | -16.09% | - | Upgrade
|
| Free Cash Flow Margin | -76.23% | -76.23% | -89.08% | -60.79% | -23.41% | - | Upgrade
|
| EBITDA | -7.54 | -7.54 | -7.97 | -4.83 | -0.71 | - | Upgrade
|
| EBITDA Margin | -195.39% | -195.39% | -97.61% | -53.33% | -13.05% | - | Upgrade
|
| D&A For EBITDA | 0.87 | 0.87 | 1.35 | 0.74 | 0.12 | - | Upgrade
|
| EBIT | -8.41 | -8.41 | -9.32 | -5.58 | -0.83 | -0.01 | Upgrade
|
| EBIT Margin | -217.87% | -217.87% | -114.19% | -61.55% | -15.24% | - | Upgrade
|
| Advertising Expenses | 0.37 | 0.37 | 1.28 | 1.58 | 0.82 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.